G1 Therapeutics' breast cancer therapy fails late-stage trial
24/06/2024 11:36
June 24 (Reuters) - G1 Therapeutics GTHX.O said on Monday its therapy for a type of breast cancer did not meet the main goal of overall survival in a late-stage trial. (Reporting by Christy Santhosh; Editing by Tasim Zahid) ((Christy.Santhosh@thomsonreuters.com;))
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify